Biogen
BIIB
BIIB
1,121 hedge funds and large institutions have $60B invested in Biogen in 2017 Q4 according to their latest regulatory filings, with 167 funds opening new positions, 398 increasing their positions, 384 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,121
Holders Change
+108
Holders Change %
+10.66%
% of All Funds
25.46%
Holding in Top 10
28
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-26.32%
% of All Funds
0.64%
New
167
Increased
398
Reduced
384
Closed
48
Calls
$989M
Puts
$1.44B
Net Calls
-$456M
Net Calls Change
-$187M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$618M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$232M |
| 3 |
PC
PointState Capital
New York
|
+$157M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$123M |
| 5 |
JPMorgan Chase & Co
New York
|
+$106M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$684M |
| 2 |
TCIM
TIAA CREF Investment Management
New York
|
-$230M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$160M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$155M |
| 5 |
O
OrbiMed
New York
|
-$127M |
